Factors Influencing the Association of 24-hour National Institutes of Health Stroke Scale & 90-day Modified Rankin Score.
Acute ischemic stroke
Cerebrovascular disease
Clinical outcomes
Modified Rankin Scale
National Institutes of Health Stroke Scale
Journal
Clinical neuroradiology
ISSN: 1869-1447
Titre abrégé: Clin Neuroradiol
Pays: Germany
ID NLM: 101526693
Informations de publication
Date de publication:
15 Oct 2024
15 Oct 2024
Historique:
received:
29
05
2024
accepted:
30
08
2024
medline:
15
10
2024
pubmed:
15
10
2024
entrez:
15
10
2024
Statut:
aheadofprint
Résumé
The modified Rankin Scale (mRS) at 90 days is the primary outcome in most acute stroke studies, but the long follow-up period has disadvantages. The National Institutes of Health Stroke Scale (NIHSS) at 24 h shows a strong, but imperfect, association with 90-day mRS. This study examines the association between 24-hour NIHSS and 90-day mRS and reasons for discrepancies. Data are from the ESCAPE-NA1 thrombectomy patients. To address the non-normality distribution of the NIHSS and include deceased patients, a 7-point ordinal score was generated by grouping 24-hour NIHSS. The association of ordinal 24-hour NIHSS and 90-day mRS was assessed with adjusted ordinal logistic regression. Differences in baseline and treatment/post-treatment variables were compared between patients with discordant and concordant outcomes. One-thousand-seventy-six patients with available 24-hour NIHSS and 90-day mRS were included (median 24-hour NIHSS 6[IQR: 2-14], median 90-day mRS 2[IQR: 1-4]). Ordinal 24-hour NIHSS was associated with 90-day mRS (adjusted cOR 2.53 [95%CI 2.33-2.74]). Forty-eight (4.5%) patients had discordant outcomes. Of those, 19(1.8%) had 24-hour NIHSS < 6 and 90-day mRS5-6; all of which had ≥ 1 severe adverse event, most commonly pneumonia (6[31.6%]) or recurrent stroke (4[21.1%]). Twenty-nine patients (2.7%) had 24-hour NIHSS > 14 and 90-day mRS 0-2. In these patients, baseline NIHSS and ASPECTS was lower, and collateral status was worse. An ordinal NIHSS score that includes death at 24 h shows a strong association with 90-day mRS, suggesting that it could be used as an alternative outcome. Patients with discrepant outcomes differed from the remaining patients regarding their baseline NIHSS, ASPECTS, collateral status, and post-stroke complications.
Identifiants
pubmed: 39404848
doi: 10.1007/s00062-024-01459-3
pii: 10.1007/s00062-024-01459-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
Références
Donkor ES. Stroke in the 21(st) century: a snapshot of the burden, epidemiology, and quality of life. Stroke Res Treat. 2018; https://doi.org/10.1155/2018/3238165 .
doi: 10.1155/2018/3238165
pubmed: 30598741
pmcid: 6288566
Goyal M, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723–31. https://doi.org/10.1016/s0140-6736(16)00163-x .
doi: 10.1016/s0140-6736(16)00163-x.
pubmed: 26898852
Robbins BT, Howington GT, Swafford K, Zummer J, Woolum JA. Advancements in the management of acute ischemic stroke: a narrative review. J Am Coll Emerg Physicians Open. 2023;4(1):e12896. https://doi.org/10.1002/emp2.12896 .
doi: 10.1002/emp2.12896
pubmed: 36817082
pmcid: 9930740
Menon BK, et al. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial. Lancet. 2022;400(10347):161–9. https://doi.org/10.1016/s0140-6736(22)01054-6 .
doi: 10.1016/s0140-6736(22)01054-6.
pubmed: 35779553
Saver JL, et al. Thrombectomy for distal, medium vessel occlusions: a consensus statement on present knowledge and promising directions. Stroke. 2020;51(9):2872–84. https://doi.org/10.1161/STROKEAHA.120.028956 .
doi: 10.1161/STROKEAHA.120.028956
pubmed: 32757757
Powers WJ, et al. Guidelines for the early management of patients with acute Ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute Ischemic stroke: a guideline for Healthcare professionals from the American heart association/American stroke association. Stroke. 2019;50(12):e344–e418. https://doi.org/10.1161/STR.0000000000000211 .
doi: 10.1161/STR.0000000000000211
pubmed: 31662037
Turc G, et al. European Stroke Organisation (ESO)—European Society for Minimally Invasive Neurological Therapy (ESMINT) Guidelines on Mechanical Thrombectomy in Acute Ischemic Stroke. J Neurointerv Surg. 2023;15(8):e8. https://doi.org/10.1136/neurintsurg-2018-014569 .
doi: 10.1136/neurintsurg-2018-014569
pubmed: 30808653
van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604–7. https://doi.org/10.1161/01.str.19.5.604 .
doi: 10.1161/01.str.19.5.604
pubmed: 3363593
Kasner SE. Clinical interpretation and use of stroke scales. Lancet Neurol. 2006;5(7):603–12. https://doi.org/10.1016/s1474-4422(06)70495-1 .
doi: 10.1016/s1474-4422(06)70495-1.
pubmed: 16781990
Polding LC, et al. Quality of life in physical, social, and cognitive domains improves with Endovascular therapy in the DEFUSE 3 trial. Stroke. 2021;52(4):1185–91. https://doi.org/10.1161/strokeaha.120.031490 .
doi: 10.1161/strokeaha.120.031490
pubmed: 33596675
pmcid: 7987886
Pu J, et al. Combination of 24-hour and 7‑day relative neurological improvement strongly predicts 90-day functional outcome of endovascular stroke therapy. J Stroke Cerebrovasc Dis. 2018;27(5):1217–25. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.11.042 .
doi: 10.1016/j.jstrokecerebrovasdis.2017.11.042
pubmed: 29305274
Rangaraju S, Frankel M, Jovin TG. Prognostic value of the 24-hour neurological examination in anterior circulation Ischemic stroke: a post hoc analysis of two randomized controlled stroke trials. Interv Neurol. 2016;4(3-4):120–9. https://doi.org/10.1159/000443801 .
doi: 10.1159/000443801
pubmed: 27051408
pmcid: 4817381
Chalos V, et al. National institutes of health stroke scale: an alternative primary outcome measure for trials of acute treatment for Ischemic stroke. Stroke. 2020;51(1):282–90. https://doi.org/10.1161/strokeaha.119.026791 .
doi: 10.1161/strokeaha.119.026791
pubmed: 31795895
Hill MD, et al. Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial. Lancet. 2020;395(10227):878–87. https://doi.org/10.1016/S0140-6736(20)30258-0 .
doi: 10.1016/S0140-6736(20)30258-0.
pubmed: 32087818
Ganesh A, et al. Assessment of discrepancies between follow-up infarct volume and 90-day outcomes among patients with Ischemic stroke who received Endovascular therapy. JAMA Netw Open. 2021;4(11):e2132376–1. https://doi.org/10.1001/jamanetworkopen.2021.32376 .
doi: 10.1001/jamanetworkopen.2021.32376
pubmed: 34739060
pmcid: 8571657
Saver JL, Altman H. Relationship between neurologic deficit severity and final functional outcome shifts and strengthens during first hours after onset. Stroke. 2012;43(6):1537–41. https://doi.org/10.1161/strokeaha.111.636928 .
doi: 10.1161/strokeaha.111.636928
pubmed: 22492517
pmcid: 3509751
Katano T, et al. National institutes of health stroke scale score less than 10 at 24 hours after stroke onset is a strong predictor of a favorable outcome after mechanical Thrombectomy. Neurosurgery. 2022;91(6):936–42. https://doi.org/10.1227/neu.0000000000002139 .
doi: 10.1227/neu.0000000000002139
pubmed: 36136364
pmcid: 9632941
Kobeissi H, Ghozy S, Seymour T, Bilgin C, Kadirvel R, Kallmes D. Early neurological deterioration as a predictor of outcomes after endovascular thrombectomy for stroke: A systematic review and meta-analysis. Interv Neuroradiol. 2022; https://doi.org/10.1177/15910199221135289 .
doi: 10.1177/15910199221135289
pubmed: 36852503
Harrison JK, McArthur KS, Quinn TJ. Assessment scales in stroke: clinimetric and clinical considerations. Clin Interv Aging. 2013;8:201–11. https://doi.org/10.2147/cia.S32405 .
doi: 10.2147/cia.S32405
pubmed: 23440256
pmcid: 3578502
Dutrieux RD, van Eijk M, van Mierlo ML, van Heugten CM, Visser-Meily JM, Achterberg WP. Discharge home after acute stroke: differences between older and younger patients. J Rehabil Med. 2016;48(1):14–8. https://doi.org/10.2340/16501977-2045 .
doi: 10.2340/16501977-2045
pubmed: 26667264
ElHabr AK, et al. Predicting 90-day modified Rankin Scale score with discharge information in acute ischaemic stroke patients following treatment. BMJ Neurol Open. 2021;3(1):e177. https://doi.org/10.1136/bmjno-2021-000177 .
doi: 10.1136/bmjno-2021-000177
pubmed: 34250487
pmcid: 8231000
Gu M, Huang H. Effect of early rehabilitation nursing on neurological function and quality of life of patients with hemiplegia after stroke: A meta-analysis. Medicine. 2023;102(34):e34919. https://doi.org/10.1097/md.0000000000034919 .
doi: 10.1097/md.0000000000034919
pubmed: 37653810
pmcid: 10470741
Manchi MR, et al. Effect of inpatient rehabilitation facility care on ninety day modified Rankin score in ischemic stroke patients. J Stroke Cerebrovasc Dis. 2023;32(6):107109. https://doi.org/10.1016/j.jstrokecerebrovasdis.2023.107109 .
doi: 10.1016/j.jstrokecerebrovasdis.2023.107109
pubmed: 37031503
Liu ZY, et al. Reducing the incidence of stroke-associated pneumonia: an evidence-based practice. BMC Neurol. 2022;22(1):297. https://doi.org/10.1186/s12883-022-02826-8 .
doi: 10.1186/s12883-022-02826-8
pubmed: 35953801
pmcid: 9367053